Bromhexine is a potential drug for COVID-19; From hypothesis to clinical trials
COVID-19 (novel coronavirus disease 2019), caused by the SARS-CoV-2 virus, has various clinical manifestations and several pathogenic pathways. Although several therapeutic options have been used to control COVID-19, none of these medications have been proven to be a definitive cure. Transmembrane s...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Central Research Institute for Epidemiology
2022-05-01
|
Series: | Вопросы вирусологии |
Subjects: | |
Online Access: | https://virusjour.crie.ru/jour/article/viewFile/608/379 |